🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
The purpose of this study is to determine whether intraperitoneal immunothe...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02976142
Treatments Being Tested
This is a randomized, multicenter, phase III trial comparing induction chem...
Status
Terminated
Location
Hôpital de la Pitié-Salpétrière
Start Date
2009-01
Trial ID
NCT00828386
Treatments Being Tested
The purpose of this trial is to investigate the efficacy of cetuximab in co...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00122460
The primary purpose of this study is to help answer the following research ...
Status
Completed
Location
Highlands Oncology Group
Start Date
2010-04
Trial ID
NCT01099358
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of combina...
Status
Completed
Location
Asan Medical Center
Start Date
2018-09-04
Trial ID
NCT03524508
The aim of the study is to assess if gemcitabine in combination with carbop...
Status
Completed
Location
Loh Guan Lye Specialist Centre
Start Date
2008-01
Trial ID
NCT00697905
Treatments Being Tested
This is a randomized noninferiority multicenter trial. Patients will be str...
Status
Active Not Recruiting
Location
National Cancer Center
Start Date
2017-10-20
Trial ID
NCT03306901
Treatments Being Tested
The objective of this study is to evaluate the efficacity of the combinatio...
Status
Completed
Location
Centre Leon Berard
Start Date
2021-02-04
Trial ID
NCT04356170
Treatments Being Tested
Study to evaluate the efficacy of treatment by radiotherapy and pembrolizum...
Status
Recruiting
Location
Institut Sainte Catherine
Start Date
2021-12-01
Trial ID
NCT04747054
Treatments Being Tested